All News

RNL, over, microphone

RheumNow Live 2021 Now Available for All

Jack Cush, MD

RheumNow Live (RNL) for 2021 was held March 20 - 21 in Fort Worth, TX, and now all can partake in the meeting - by video, podcast or by signing up for Tuesday Nite Rheumatology (TNR).

Read Article
ild.jpg

Risk Factors for Rheumatoid Arthritis-associated Interstitial Lung Disease

Jack Cush, MD

Sparks and colleagues have published a matched cohort analysis demonstrating risk factors that may augment the risk of rheumatoid arthritis (RA)-associated interstitial lung disease (ILD), especially the combination of obesity, high CRP, high MD-HAQ and >30 pack-year smoking h

Read Article
NSAIDs.pills_.caps_.jpg

NSAID Safety with COVID-19 Infection

Jack Cush, MD

NSAIDs do not affect COVID outcomes; here we are nearly 16 months into the pandemic, and this is the common sense conclusion of a recent trial published in Lancet Rheumatology.

Read Article
RheumNow Podcast square

RheumNow Podcast – Falling or Falling in Love?

Jack Cush, MD

Dr. Jack Cush reviews the best journal articles from the past week on RheumNow.com.

Read Article
microbio2.jpg

Unique Oral Microbiome in Early and Pre-Clinical RA

Jack Cush, MD

An oral microbiome study of rheumatoid arthritis patients suggests that periodontal condition in patients with early rheumatoid arthritis and individuals at risk of RA.

Read Article
Step, down, arrow, blocks

ARTIC REWIND - Don't Half DMARD Therapy

Jack Cush, MD

The ARTIC-REWIND study examined rheumatoid arthritis (RA) patients in remission on conventional synthetic disease-modifying antirheumatic drugs (csDMARDs) to see if they could "step-down" their csDMARDs theray; but  the study showed that 25% those who went on half-dose experienced disease fl

Read Article
Level, monitor, calculate, glucose, diabetes

Drug Monitoring Ineffective with Infliximab Treatment

Jack Cush, MD

The predictive value of therapeutic drug monitoring (TDM) while on biologics is debateable; gastroenterology routinely relies on TDM, while rheumatologists do not.

Read Article
RheumNow Podcast square

RheumNow Podcast – Uppers and Downers

Jack Cush, MD

Dr. Jack Cush reviews the news and journal reports from the past week on RheumNow.com.

Read Article
AE, Side effects

Predictors of Methotrexate Toxicity

Jack Cush, MD

A metanalysis showed that while adverse events (AEs) are common when methotrexate is used in rheumatoid arthritis or inflammatory arthritis patients, serious AEs ranged from 2.1 to 9.5% and drug discontinuations ranged from 6.7% to 15.5%, mostly due to gastrointestinal events. 

Read Article
RheumNow Podcast square

RheumNow Podcast – Coconspirators: RA and Lung Disease

Jack Cush, MD

Dr. Jack Cush reviews and discusses more than a dozen news and journal articles from the past week on RheumNow.com.

Read Article
News Feature: Risk Factors for Rheumatoid Arthritis-associated Interstitial Lung Disease https://t.co/ps8JeRUtJf https://t.co/Sn6ykG9ZuE

Links:

Dr. John Cush RheumNow ( View Tweet)
Sulfasalazine may be in short supply. FDA shortage lists shortage with drug return in July or 4th quarter of 2021. ASHP site also notes several generic maker shortages but they suggest resolution mid-May or July https://t.co/XYyraO6Z4z https://t.co/tm50S7ov9K https://t.co/QPWIitYkpp

Links:

Dr. John Cush RheumNow ( View Tweet)
Systematic review of the epidemiology of #RA shows average point and period prevalence of RA to be 51 to 56 per 10,000, respectively. Higher with rheumatologist diagnosis (81 per 10,000). https://t.co/5AeNdmBLJO

Links:

Dr. John Cush RheumNow ( View Tweet)

News Feature: Unique Oral Microbiome in Early and Pre-Clinical RA An oral microbiome study of rheumatoid arthritis (RA) patients suggests that periodontal condition in patients with early rheumatoid arthritis (ERA) and individuals at risk of RA. https://t.co/r3kT52MByC https://t.co/MocZ6PXZzA

Links:

Dr. John Cush RheumNow ( View Tweet)
New podcast alert! Falling or Falling in Love (5.7.2021) Dr Jack Cush reviews the best journal articles of the week from RheumNow https://t.co/HyAPN2rM3L https://t.co/C5XtqthO8I

Links:

Dr. John Cush RheumNow ( View Tweet)
Falls are not uncommon in #RA patients; significant risk factors for falls include being elderly, un-married, higher pain scores, reported dizziness taking psychotropic medications and having lower HRQoL scores https://t.co/a8qA7n68q5

Links:

Dr. John Cush RheumNow ( View Tweet)

New download available! Osteoarthritis vs. Rheumatoid Arthritis https://t.co/qvVEcKqNAM https://t.co/3f8sRSgyQo

Links:

Dr. John Cush RheumNow ( View Tweet)
Real world comparision of baricitinib (n 138) and tofacitinib (n 156) in #RA patients shows at wk 24, BARI out performed TOFA - CDAI remission (40.4 vs 28.3%) and CDAI LDA (81.6 vs 69.3%); safety signals were equal between groups. https://t.co/0quNNGB18K

Links:

Dr. John Cush RheumNow ( View Tweet)

Coconspirators: RA and Lung Disease Download this week's RheumNow podcast, where Dr. Cush reviews the news and journal articles for the last week. https://t.co/MJbfJANWwt https://t.co/PUqewOvBjZ

Links:

Dr. John Cush RheumNow ( View Tweet)
Diary study of 79 FM, 86 RA, 33 w/ both FM/RA shows that compared to RA, pts with FM have worse daily well-being, negative affect, more isolation, inability to complete plan. FM had more perceived stigma and lower well-being. https://t.co/YZdhvYghuI

Links:

Dr. John Cush RheumNow ( View Tweet)

How well do you know this week's rheumatology news?
Take the rheumIQ quiz
Take the RheumIQ Quiz

×